IUML MP: Clear production of generic medicine for spinal disease

As per experts, Beeran said, if generic medicine is produced, this medicine which costs Rs 6.2 lakh for one bottle, can be produced for Rs 3,063.

• By: Express News Service
• New Delhi | February 8, 2025 05:33 AM IST

1 min read

Raising the issue, Beeran, an MP from Kerala, said that as per estimated statistics, almost 8,000 to 25,000 people get affected by SMA every year in India and there are treatments to manage SMA but there is no cure.

Indian Union Muslim League (IUML) member in Rajya Sabha Haris Beeran Friday sought urgent intervention of the Union Health Ministry to allow production of generic medicines for Spinal Muscular Atrophy (SMA), a rare genetic disorder that affects the nerve cells in the spinal cord.

Raising the issue, Beeran, an MP from Kerala, said that as per estimated statistics, almost 8,000 to 25,000 people get affected by SMA every year in India and there are treatments to manage SMA but there is no cure. He said the cost of the medicine currently available is too high for a common man.

You have exhausted your
monthly limit of free stories.

Read more stories for free
with an Express account.

Register

Already have an account? Sign In

This story is exclusive to subscribers. Become one now. Use code IE10

Subscribe Now

Already a subscriber? Sign In

This premium article is free for now.

Register to continue reading this story

Free Read

Already have an account? Sign In

This story is exclusive to subscribers. Become one now. Use code IE10

Subscribe Now

This content is exclusive for our subscribers.

Subscribe now to get unlimited access to The Indian Express exclusive and premium stories.

Continue

Already a subscriber? Sign In